Deep search
Search
Images
Videos
Maps
News
Shopping
Copilot
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
59m
on MSN
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...
32m
Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...
WXYZ
46m
FDA approves Spravato as first stand-along nasal spray to treat drug-resistant depression
In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Hughes Fire prompts evacs
Los Angeles wildfire updates
Passes Laken Riley Act
Nashville school shooting
Legendary guitarist dies
Jan. 6 rioter arrested again
Prince Harry settles suit
Court: Elephants can't sue
Launches bid for governor
Soda button reinstalled
Trump unveils $500B AI plan
Files $500M defamation suit
Turns down plea deal
Can target schools, churches
Meta ex-COO sanctioned
Bryan pastor found guilty
1st Japanese elected to HOF
2,000-year-old statue found
Voice of Navy football dies
Troops to secure border
Raising prices again
The Band's keyboardist dies
UN seeks $910M for Nigeria
Faces new allegations
Silk Road founder pardoned
Murder charge upheld
Record-breaking snow
DEI staff placed on leave
Drives Ferrari F1 car
Houthi rebels release crew
Remains of WI pilot ID'd
Ex-El Salvador pres dies
Loses bid for new trial
Related topics
depression
United States
Johnson & Johnson
Spravato
Food and Drug Administration
Feedback